Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA

Rheumatology

Volumn 47, Issue 7, 2008, Pages 976-979

  Parker, J C ^a   Burlingame, R W ^b   Webb, T T ^b   Bunn, C C ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b INOVA DIAGNOSTICS INC   (United States)

Author keywords

Anti nuclear antibody; Anti ribonucleic acid polymerase antibody; Autoantibodies; Enzyme linked immunosorbent assay; Indirect immunofluorescence; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; DNA DIRECTED RNA POLYMERASE III ANTIBODY; ENZYME ANTIBODY; GRANULOCYTE ANTIBODY;

ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOPRECIPITATION; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 45749138398     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken201     Document Type: Article

References (24)

1. Denton CP, Black CM. Scleroderma - clinical and pathological advances. Best Pract Res Clin Rheumatol 2004;18:271-90.
2. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
3. Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 1998;37:15-20.
4. Kuwana M, Okano Y, Junichi K, Takeshi T, Medsger TA. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994;37:902-6.
5. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007;34:104-9.
6. Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol 2007;34:1528-34.
7. Kuwana M, Kaburaki J, Okano Y, Takeshi T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994;37:75-83.
8. Penn H, Howie AJ, Kingdon EJ et al. Scleroderma renal crisis: patient characteristics and long term outcomes. Q J Med 2007;100:485-94.
9. Sanders PW, Herrera GA, Ball GV. Acute renal failure without fibrotic skin changes in progressive systemic sclerosis. Nephron 1988;48:121-5.
10. Molina JF, Anaya JM, Cabrera GE, Hoffman E, Espinoza LR. Systemic sclerosis sine scleroderma: An unusual presentation in scleroderma renal crisis. J Rheumatol 1995;22:557-60.
11. Phan TG, Cass A, Gillin A, Trew P, Fertig A, Sturgess A. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma. J Rheumatol 1999;26:2489-92.
12. Laing CM, Roberts R, Lightstone L et al. A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: Case outcome. Br Med J 2007;335:205-08.
13. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest 1993;91:1399-404.
14. Satoh M, Ajmani AK, Ogasawara T et al. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. J Clin Invest 1994;94:1981-9.
15. Satoh M, Kuwana M, Ogasawara T et al. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients. J Immunol 1994;153:5838-48.
16. Kuwana M, Kimura K, Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognised by systemic sclerosis sera - application to enzyme-linked immunosorbent assay. Arthritis Rheum 2002;46:2742-7.
17. Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA. Enzyme-linked immunosorbent assay for the detection of Anti-RNA polymerase III antibody. Arthritis Rheum 2005;52:2425-32.
18. Reimer G, Rose KM, Scheer U, Tan EM. Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest 1987;79:65-72.
19. Okano Y, Steen VD, Medsger TA. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993;119:1005-13.
20. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
21. Bunn CC, Kveder T. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In: Van Venrooij WJ, Maini RN, eds. Manual of biological markers of disease. Dordrecht, The Netherlands: Kluwer Academic, 1993;A3.1-12.
22. Humbel RL. Detection of antinuclear antibodies by indirect immunofluorescence. In: Van Venrooij WJ, Maini RN, eds. Manual of biological markers of disease. Dordrecht, The Netherlands: Kluwer Academic, 1993:A2.1-16.
23. Codullo V, Morozzi G, Bardoni A et al. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheum 2007;25:373-7.
24. Yamasaki Y, Honkanen-Scott M, Hernandez L et al. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies. Arthritis Rheum 2006;54:3051-6.